Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
Austria Belgium Brazil Canada Denmark Finland France Germany Hungary Iceland Ireland Italy Luxembourg The Netherlands Norway Poland Spain Sweden Switzerland UK USA
A wave of companies is turning medical testing into a consumer product, reshaping how people monitor their health and how investors view the wellness economy.
Founded in 2015 in Chicago, Tempus has emerged as a leader in precision medicine, utilizing advanced analytics, artificial intelligence, and machine learning to personalize cancer treatment.